Vestal Point Capital, LP Insmed Inc Transaction History
Vestal Point Capital, LP
- $1.32 Trillion
- Q3 2024
A detailed history of Vestal Point Capital, LP transactions in Insmed Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,600,000 shares of INSM stock, worth $117 Million. This represents 8.86% of its overall portfolio holdings.
Number of Shares
1,600,000
Previous 750,000
113.33%
Holding current value
$117 Million
Previous $50.3 Billion
132.44%
% of portfolio
8.86%
Previous 3.75%
Shares
3 transactions
Others Institutions Holding INSM
# of Institutions
465Shares Held
182MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$920 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$768 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$477 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.91B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...